Barclays

Key Findings

• Economic: Barclays’ documented nexus is principally financial: NGO research reports loans, underwriting and shareholdings involving companies supplying arms to Israel, while Barclays has also acted in the international syndicate for Israeli sovereign bonds.^{1, 2}
• Political: Barclays maintains Gaza-specific public FAQs and its senior leadership has publicly defended defence-sector financing while describing the bank’s approach as aligned with government policy.^{3, 4}
• Settlements: The Don’t Buy Into Occupation coalition identified Barclays among major European creditors to businesses active in West Bank settlements; Barclays itself is not identified on the OHCHR settlement-business database.^{5, 6}
• Not found: No public evidence identified of Barclays directly supplying military equipment, operating military technology, holding Israeli military or intelligence technology contracts, or operating branches in settlements.^{7, 8}

Target Profile

Key Facts:

• Barclays Bank PLC received a Bank of Israel foreign-bank licence on 15 August 2011, following a representative-office presence since late 2008.¹²
• Barclays’ current Israel-facing corporate and investment-banking office is in Tel Aviv.¹³
• Barclays PLC is the group parent and Barclays Bank PLC is its wholly owned subsidiary.⁹

Executive Summary

Barclays’ documented Israel/Palestine nexus is primarily financial and institutional rather than operational military or digital provision. The bank operates a licensed foreign-bank branch and corporate and investment-banking presence in Tel Aviv. It has also maintained historical ties to Israel’s technology sector, including an Israel Development and Engineering Center arrangement with Ness Technologies from approximately 2011 until Barclays ended the arrangement in 2018, and the Rise Tel Aviv accelerator, which ran documented cohorts through 2019. Later continuation of the R&D function or accelerator activity is not confirmed by the reviewed record.^{12, 14, 15}

The strongest documented vector is financial exposure. NGO coalitions reported that, as of their May 2024 research, Barclays held more than £2 billion in shares and provided £6.1 billion in loans and underwriting to nine companies described as supplying arms or military technology used by Israel. The reported figures are NGO-sourced aggregates, not Barclays-disclosed totals, and Barclays disputes that client-driven trading and custody positions make it an investor or shareholder in the ordinary sense.^{1, 16} Barclays’ reported Elbit Systems position fell from 16,345 shares, valued at more than US$3.4 million in a May 2024 filing, to zero by late October 2024. Campaigners described this as divestment; Barclays rejected that characterisation.¹⁷

Barclays is also documented as part of a syndicate of international banks underwriting Israeli government bonds. Research identified two Barclays-linked issuances after 7 October 2023: US$278 million in November 2023 and US$223 million in January 2024. Barclays publicly reaffirmed its primary-dealer role after reports that it had considered withdrawing from auctions in August 2024. However, later research reported no public Barclays syndicated underwriting after January 2024, notwithstanding the bank’s continuing public description of its syndicate role; reporting also indicated continuing purchases through Israeli domestic auctions. This distinction remains material and unresolved in the public record.^{2, 18}

No public evidence identified of Barclays manufacturing, exporting or directly supplying weapons, munitions, military equipment, tactical products, logistics, base services, offensive cyber capabilities, or military/intelligence technology to Israel. No public evidence identified of a Barclays contract with the Israeli Ministry of Defence, IDF, Israeli intelligence agencies, Israel Prison Service or Border Police. The bank is not identified on the OHCHR database of businesses involved in Israeli settlements, although coalition research identifies it as a creditor to companies active in settlements.^{6, 7}

On the V6.5 evidence-only, human-vetted framework, the material supports no Military or Digital score, but high Economic and substantial Political scores reflecting financial exposure, sovereign-bond activity, settlement-linked creditor findings, corporate communications and institutional persistence. The final result is BRS 734, Tier B (Severe Complicity).

Timeline of Relevant Events

Corporate Overview

Barclays PLC is a UK-founded, UK-domiciled banking group headquartered in London. Barclays Bank PLC is its wholly owned subsidiary. The record reviewed does not establish Israeli incorporation, Israeli tax residence, Israeli beneficial ownership, an Israeli government board appointment, or an Israeli state ownership stake.^{9, 10}

Barclays’ current direct institutional link is a Bank of Israel-licensed foreign-bank branch and Tel Aviv corporate and investment-banking office. A State of Israel prospectus described Barclays Bank PLC as one of four foreign-bank branches operating in Israel “on a smaller scale.” Barclays’ Israeli-branch disclosure states that its investment-marketing licence was cancelled on 30 November 2014 because it serves eligible clients under exemptions in Israel’s Advisory Law.^{12, 13, 23}

The group’s history in the territory predates the State of Israel through the Anglo-Egyptian Bank, absorbed into Barclays Bank (Dominion, Colonial & Overseas) in 1925. Barclays also held a 50.1% interest in Barclays Discount Bank Limited from 1972 until its complete sale to Israel Discount Bank in February 1993. That entity is divested historical activity, not a current Israeli subsidiary.^{24, 25}

Israeli technology-ecosystem relationships included the 2011–2018 Ness Technologies R&D services arrangement, the Rise Tel Aviv accelerator, a JVP Play accelerator partnership, and a reported strategic investment in Israeli AI data-security startup Velotix. These are documented commercial and minority-style relationships, not evidence of Barclays acquiring or controlling an Israeli operating company.^{14, 19, 22, 26}

Domain Summaries

Military: Military

Mechanism of Involvement

No public evidence identified of a direct Barclays contract, tender, framework agreement or memorandum of understanding with the Israeli Ministry of Defence, IDF, Israel Prison Service or Israel Border Police. Barclays is a financial institution, not a defence manufacturer, exporter, military contractor, logistics provider or supplier of tactical goods.⁷

Its documented connection to arms manufacturers is financial. NGO research identifies shareholdings, loans and underwriting involving BAE Systems, Boeing, Caterpillar, Elbit Systems, General Dynamics, QinetiQ, Raytheon/RTX, Rolls-Royce and Ultra Electronics. Those companies are reported to supply weapons, components, platforms or military technology used by Israel; Barclays is not documented as supplying those products itself.^{1, 16}

Counter-Arguments and Evidence Limits

Barclays’ strongest defence is that it does not invest its own capital in companies supplying weapons used by Israel, and that positions shown on share registers may arise from client-driven transactions and market-making. It states that it is not an investor in Elbit “in that sense.”^{3, 17}

The Elbit position fell to zero in late October 2024, reducing a documented direct equity exposure. Barclays disputes that this was a divestment, so the public record supports the sell-down but not a settled account of its cause or character.¹⁷ NGO financial aggregates should not be treated as Barclays-confirmed exposure totals. No public evidence identified of direct supply, co-production, technology transfer or military procurement by Barclays.^{1, 7}

Named Entities and Evidence Map

• Elbit Systems: 16,345 Barclays-reported shares in May 2024; zero reported by late October 2024.¹⁷
• Nine-company NGO portfolio: BAE Systems, Boeing, Caterpillar, Elbit Systems, General Dynamics, QinetiQ, Raytheon/RTX, Rolls-Royce and Ultra Electronics.^{1, 16}
• Israeli sovereign bonds: Barclays participated as an international underwriter; this is capital-markets activity, not defence contracting.²

Digital: Digital

Mechanism of Involvement

No public evidence identified of Barclays providing technology, cloud services, surveillance systems, AI systems, data infrastructure, cyber capabilities or digital services to Israeli state, military, intelligence, settlement or occupied-territory customers.⁸

Barclays’ publicly disclosed security partner is Microsoft. Its major cloud infrastructure partners include AWS, Microsoft, Oracle Cloud Infrastructure and HPE GreenLake; the disclosed HPE deployment covers UK, US and Asia hubs, with no Israel-hosted component identified. Barclays is not a Project Nimbus participant.^{27, 28}

A historical Barclaycard deployment of Verint contact-centre software is documented, including a current Barclays role supporting Verint systems. That is a Barclays contact-centre technology relationship, not evidence of Israeli state, military or surveillance use. No confirmed direct Barclays relationship with Check Point, Wiz, CyberArk, SentinelOne, Claroty, Palo Alto Networks, NICE or NICE Actimize was identified.²⁹

Counter-Arguments and Evidence Limits

The Israeli branch is licensed and supervised, but the reviewed record does not establish its data-centre use, system architecture, customer-data categories, remote-access permissions, Israeli personnel access or Israeli authority access to Barclays-held customer data. The available evidence therefore cannot confirm or disconfirm Israel-related data exposure under the digital sovereignty principle.^{12, 23, 30}

Barclays previously operated an Israel Development and Engineering Center arrangement and Rise Tel Aviv accelerator. Their later operational status, technical remit, data access and integration into Barclays systems are unconfirmed. The accelerator’s closure was announced in 2025.^{14, 20, 22}

Named Entities and Evidence Map

• Microsoft: publicly named security-strategy partner.²⁷
• HPE GreenLake: Barclays private-cloud relationship, expanded in 2024; no Israel-hosted component identified.²⁸
• Verint: historical and apparently continuing contact-centre deployment; no evidence links it to Israeli state or military use.²⁹
• Rise Tel Aviv / Ness Technologies: historical Israeli technology-ecosystem relationships, with later operational scope unresolved.^{14, 20}

Economic: Economic

Mechanism of Involvement

The economic nexus is the dossier’s strongest domain. Barclays has a licensed banking presence in Israel and a documented international capital-markets role in Israeli sovereign-bond underwriting. Research published in 2025 identified Barclays among seven banks underwriting Israeli sovereign bonds issued between 7 October 2023 and January 2025; later reporting found no publicly identified Barclays syndicated underwriting after January 2024.^{2, 31}

NGO research reported substantial Barclays equity, lending and underwriting exposure to nine arms-related companies supplying Israel. The May 2024 coalition figure was more than £2 billion in shares and £6.1 billion in loans and underwriting; a US-dollar presentation of the same reported research gave over US$2.5 billion and US$7.6 billion respectively. These represent different reporting presentations and should not be added together.^{1, 16}

DBIO research identified Barclays among major European creditors to companies active in West Bank settlements. The 2025 DBIO material gives collective figures, but does not provide a Barclays-specific figure that can be isolated from the published material.^{5, 32}

Counter-Arguments and Evidence Limits

Barclays says its capital-markets activity does not constitute direct funding of Israel and characterises its bond role as connecting issuers and investors through debt auctions. It also disputes NGO characterisation of client-driven holdings and trading positions as proprietary investment.³

Barclays’ reported Elbit holding is now zero, and reporting indicates an apparent cessation of public international syndicated Israeli-bond underwriting after January 2024. Conversely, the reported continuation of domestic Israeli bond purchases and Barclays’ continuing public syndicate description mean that a full exit from Israeli sovereign-bond activity is not established.^{2, 17}

No public evidence identified of Barclays acting as an importer, retailer, distributor or producer of Israeli- or settlement-origin physical goods, or of product-origin-labelling violations. Barclays is not identified on the OHCHR settlement-business database.^{6, 33}

Named Entities and Evidence Map

• State of Israel: Barclays was part of the international sovereign-bond underwriting syndicate; post-January 2024 activity is contested or unresolved in public reporting.^{2, 18}
• Elbit Systems: reported holding reduced to zero by late October 2024.¹⁷
• General Dynamics: a June 2026 filing reported a US$152.03 million Barclays stake, reduced quarter-on-quarter.³⁴
• DBIO settlement-linked companies: Barclays was identified as a creditor in coalition research; Barclays-specific 2025 totals were not isolated.^{5, 32}

Political: Political

Mechanism of Involvement

Barclays has created a sustained Gaza-specific corporate communications architecture, including pages addressing its links to the defence sector, Israeli-state funding and the Gaza conflict. The bank expresses concern about suffering and calls for a peaceful solution, while not adopting the legal or factual characterisations advanced by campaign groups or the UN Special Rapporteur.^{3, 35}

Venkatakrishnan publicly defended defence-sector financing in June 2024, describing financed companies as making defence equipment alongside civilian products and referring to democratically elected governments. Higgins stated at AGMs that Barclays follows British government policy on defence financing and would not discuss financing policies for specific clients.^{4, 11}

Barclays is named in the UN Special Rapporteur’s 2025 report as one of the banks said to have helped Israel contain the interest-rate premium following a credit downgrade. This is a documented financial-policy nexus; it does not establish lobbying, military contracting or direct state partnership.^{31, 36}

Counter-Arguments and Evidence Limits

Barclays’ most substantial public defence is that its defence-sector financing is policy-neutral financial services to companies supported by democratic governments, rather than a bespoke Israel policy. Its December 2025 Defence and Security Statement is framed around NATO allies and democratically elected governments generally.^{4, 37}

No public evidence identified of Barclays lobbying on Israel/Palestine policy or anti-boycott laws; direct donations to the IDF, Friends of the IDF, settlement organisations or Israeli military-welfare bodies; executives holding formal roles in pro-Israel advocacy organisations; or Barclays operating in settlements. The OECD National Contact Point complaint concerning US private-prison companies is distinct from Israel/Palestine, and the UK NCP expressly stated that acceptance for examination was not a finding against Barclays.^{6, 38}

Named Entities and Evidence Map

• C.S. Venkatakrishnan: publicly defended Barclays’ defence-sector financing.⁴
• Nigel Higgins: made recorded AGM statements on financing policy and government policy alignment.¹¹
• Israeli Accountant General: publicly welcomed Barclays’ continuation in the bond market.¹⁸
• UN Special Rapporteur: named Barclays in relation to Israeli sovereign-bond underwriting.^{31, 36}

Complicity Index Score

Method: V6.5.

• V_MAX: 8.40 Avg_OTHERS: 2.01
• BRS Score: 734 Tier: B (Severe Complicity)

V_MAX is driven by the evidence-supported economic record: documented Israeli sovereign-bond activity, financial exposure reported by NGO coalitions to arms suppliers, and creditor findings regarding settlement-linked businesses. Political reflects the bank’s Israel/Gaza-specific public posture and leadership statements, but the score preserves important limits: no direct military procurement, no digital-state nexus, and no verified settlement operation by Barclays itself.

The V6.5 method is scale-free, evidence-only and human-vetted. Scores reflect documented activity type, scale and directness rather than the severity of allegations alone.

Methodology Note

• Evidence is limited to the four supplied domain audits and their cited source record; no claim is included solely because it appears in advocacy or campaign discourse.
• Impact (I) assesses the activity type; Magnitude (M) assesses documented scale; Proximity (P) assesses directness to the relevant nexus.
• NGO estimates of holdings, loans and underwriting are identified as NGO-sourced aggregates where Barclays has not confirmed the totals.
• Divested, exited or apparently discontinued activity is mitigated: the Elbit holding fell to zero, the Ness arrangement ended in 2018, Rise was scheduled for closure in 2025, and public syndicated Israeli-bond underwriting after January 2024 is not identified.
• Entity attribution is not transitive: Barclays’ financial relationships with arms manufacturers are distinguished from those companies’ own manufacturing, exports and military contracts.
• Settlement-linked financing can inform both Economic and Political, while direct settlement operation would require separate evidence; “No public evidence identified” is used where audit checks found none.